These results indicate that when exposed to batimastat, which annuls the release of sFasL into the culture medium (Figure 1A), IPF-lung myofibroblasts lose their resistance to cell death compared to non-treated IPF cells. Here, FASLG is linked to idiopathic pulmonary fibrosis.